GENOFOCUS
About Us
Specialty Enzymes & Bio-Active Ingredients for Dietary Supplements and Cosmetics
GENOFOCUS is a South Korean company that develops and produces new microbiome drugs and healthcare ingredients using microbial metabolism. Established in 2000 as a spin-off from Korea's reputable KRIBB (Korea Research Institute of Bioscience & Biotechnology), GENOFOCUS brings expertise to specialty enzyme, nutraceutical, cosmeceutical, and biopharmaceutical industries using our core platform technology and eco-friendly processes.
GENOFOCUS has established strong internal R&D infrastructure and a diverse collaborative research network, and has commercialized various raw materials across industries.
GENOFOCUS researchs and develops various microbial strains and specialty enzymes, and discovers novel microbiome-enzyme drugs. Its subsidiary GF Fermentech is engaged in bio-healthcare ingredients, and its subsidiary Biomlogic develops microbiome-enzyme drugs.
Our vision is to lead the global Microbiome Therapeutics industry through the expansion of our bio-pharmaceutical, dietery supplement, and medical foods businesses.